注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Galectin Therapeutics Inc是一家生物技术公司,专注于开发治疗方法,以改善纤维性疾病、慢性肝病和癌症患者的生活。该公司的候选产品包括半乳糖凝集素-3抑制剂,这是一种Belapectin(GR-MD-02)和GM-CT-01。该公司的主导药物Belagulatin是一种基于碳水化合物的药物,可抑制Galectin-3蛋白,该蛋白直接参与多种炎症、纤维化和恶性疾病。该公司正在使用半乳糖凝集素-3抑制剂治疗非酒精性脂肪性肝炎(NASH)患者的晚期肝纤维化和肝硬化。该公司还设计了一项IIb/III期临床研究,即NAVIGATE试验,评估其半乳糖凝集素-3抑制剂贝拉果胶(GR-MD-02)预防非酒精性脂肪性肝炎肝硬化患者食管静脉曲张的安全性和有效性。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Kary Eldred | 50 | 2018 | Independent Director |
Kevin H. Mayo | - | - | Member of the Scientific Board |
Eric Lawitz | - | - | Member of Clinical Advisory Board |
Benjamin S. Carson | 73 | 2023 | Independent Director |
Marc Rubin | 69 | 2011 | Independent Director |
Gilbert F. Amelio | 81 | 2009 | Independent Director |
Kevin D. Freeman | 62 | 2011 | Independent Vice Chairman of the Board |
Anatole A. Klyosov | 77 | 2000 | Co-founder & Member of the Scientific Board |
Stephen A. Harrison | - | - | Member of Clinical Advisory Board |
Brent Tetri | - | - | Member of Clinical Advisory Board |
Richard E. Uihlein | 79 | 2017 | Independent Chairman |
Naga Chalasani | - | - | Member of Clinical Advisory Board |
Joel Lewis | 54 | 2017 | President, CEO & Director |
Thomas D. Schiano | - | - | Member of Clinical Advisory Board |
Ram Subramanian | - | - | Member of Clinical Advisory Board |
Arun J. Sanyal | - | - | Member of Clinical Advisory Board |
Elissa J. Schwartz | 53 | 2020 | Independent Director |
Richard A. Zordani | 51 | 2020 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核